|
E2F3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.056600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.306200E-01 |
| Normal-vs-Stage2 |
6.246600E-01 |
| Normal-vs-Stage3 |
9.913600E-01 |
| Normal-vs-Stage4 |
3.499000E-01 |
| Stage1-vs-Stage2 |
8.858000E-01 |
| Stage1-vs-Stage3 |
4.974400E-01 |
| Stage1-vs-Stage4 |
8.016400E-02 |
| Stage2-vs-Stage3 |
6.148600E-01 |
| Stage2-vs-Stage4 |
2.537800E-01 |
| Stage3-vs-Stage4 |
3.418800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.317000E-01 |
| Normal-vs-AfricanAmerican |
2.575400E-01 |
| Normal-vs-Asian |
8.468800E-01 |
| Caucasian-vs-AfricanAmerican |
3.756000E-01 |
| Caucasian-vs-Asian |
5.534800E-01 |
| AfricanAmerican-vs-Asian |
2.369000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.913600E-01 |
| Normal-vs-Female |
8.692000E-01 |
| Male-vs-Female |
4.914400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.134200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.443200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.893800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.717400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.235000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.596200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.469200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.285800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.577600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.419400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.653900E-02 |
| Classical-VS-Follicular |
4.399800E-02 |
| Classical-VS-Other |
3.470800E-01 |
| Classical-VS-Normal |
2.733200E-01 |
| Tall-VS-Follicular |
7.870600E-01 |
| Tall-VS-Other |
8.777000E-01 |
| Tall-VS-Normal |
4.490200E-01 |
| Follicular-VS-Other |
8.205800E-01 |
| Follicular-VS-Normal |
5.932400E-01 |
| Other-VS-Normal |
5.725600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.045000E-01 |
| Normal-vs-N1 |
7.438800E-01 |
| N0-vs-N1 |
6.762000E-01 |
|
|
